These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33746739)

  • 1. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review.
    Lem FF; Opook F; Lee DJH; Chee FT; Lawson FP; Chin SN
    Front Pharmacol; 2020; 11():585331. PubMed ID: 33746739
    [No Abstract]   [Full Text] [Related]  

  • 2. Traditional Chinese Medicine as Potential Therapy for COVID-19.
    Li S; Liu C; Guo F; Taleb SJ; Tong M; Shang D
    Am J Chin Med; 2020; 48(6):1263-1277. PubMed ID: 32907358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "
    Zhao ZH; Zhou Y; Li WH; Huang QS; Tang ZH; Li H
    Am J Chin Med; 2020; 48(5):1035-1049. PubMed ID: 32668970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.
    Al-Romaima A; Liao Y; Feng J; Qin X; Qin G
    J Thorac Dis; 2020 Oct; 12(10):6054-6069. PubMed ID: 33209439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.
    Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M
    Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review.
    Kröker A; Tirzīte M
    Respir Res; 2021 Nov; 22(1):304. PubMed ID: 34838020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese Medicine Induced Liver Injury.
    Teschke R
    J Clin Transl Hepatol; 2014 Jun; 2(2):80-94. PubMed ID: 26357619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art Tools to Elucidate the Therapeutic Potential of TAT-peptide (TP) Conjugated Repurposing Drug Against SARS-CoV-2 Spike Glycoproteins.
    Ansari MA; Alomary MN; Jamal QMS; Almoshari Y; Salawi A; Almahmoud SA; Khan J
    Curr Pharm Des; 2022; 28(46):3706-3719. PubMed ID: 36278465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
    Habler K; Brügel M; Teupser D; Liebchen U; Scharf C; Schönermarck U; Vogeser M; Paal M
    J Pharm Biomed Anal; 2021 Mar; 196():113935. PubMed ID: 33548872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Current Therapeutic Drugs Treating COVID-19.
    Wu R; Wang L; Kuo HD; Shannar A; Peter R; Chou PJ; Li S; Hudlikar R; Liu X; Liu Z; Poiani GJ; Amorosa L; Brunetti L; Kong AN
    Curr Pharmacol Rep; 2020; 6(3):56-70. PubMed ID: 32395418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases.
    Teschke R; Zhang L; Long H; Schwarzenboeck A; Schmidt-Taenzer W; Genthner A; Wolff A; Frenzel C; Schulze J; Eickhoff A
    Ann Hepatol; 2015; 14(1):7-19. PubMed ID: 25536637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
    Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
    Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral traditional Chinese medication for adhesive small bowel obstruction.
    Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
    Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoping insight on antiviral drugs against COVID-19.
    Ali AS; Ibrahim IM; Burzangi AS; Ghoneim RH; Aljohani HS; Alsamhan HA; Barakat J
    Arab J Chem; 2021 Oct; 14(10):103385. PubMed ID: 34909060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.
    Kheirabadi D; Haddad F; Mousavi-Roknabadi RS; Rezaeisadrabadi M; Dehghan H; Fazlzadeh A
    J Med Virol; 2021 May; 93(5):2705-2721. PubMed ID: 33463727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of the Novel Chinese Herbal Medicine Formula
    Cruz J; Trombley J; Carrington L; Cheng X
    Med Acupunct; 2021 Feb; 33(1):71-82. PubMed ID: 33613814
    [No Abstract]   [Full Text] [Related]  

  • 20. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19.
    Bibi N; Gul S; Ali J; Kamal MA
    Eur J Pharmacol; 2020 Oct; 885():173496. PubMed ID: 32841640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.